Adiuvo InvestmentsS.A.
Other financial service activities, except insurance and pension funding not elsewhere
Overview
Adiuvo Investments acquires and invests in life-science projects and biomedical technologies. The company focuses on commercializing products that support prevention, health monitoring, and patient participation in treatment, including on international markets. It also works on intellectual property protection, technology validation, and obtaining certifications needed to place products on the market.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.64
- High
- PLN 0.64
- Low
- PLN 0.61
- Volume
- 11.65K
- Avg. vol.
- 40.89K
- Market cap
- PLN 102.21M
- P/E ratio
- –
- EPS
- -PLN 0.02
- Shares outstanding
- 162.75M
- 52-week
- PLN 0.57 – 0.68
- Dividend yield
- –
- Dividend
- –
- Ex dividend date
- –
- ISIN
- PLADVIV00015
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 152.89k | USD -53.48k | USD -215.02k |
| Q1 2026 | USD 12.43k | USD -246.62k | USD -376.82k |
| Q4 2025 | USD -27.12k | USD 10.30k | USD -79.36k |
| Q3 2025 | USD 85.89k | USD -220.74k | USD -298.34k |
Results for Q3 2026:Nov 30, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2012-08-27. Active
Debt
3 closed proceedings recorded in KRZ history. Closed proceedings in history
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Dec 2, 2024 | Accelerated arrangement proceedings | Closed | |
| Oct 21, 2024 | Petition to open accelerated arrangement proceedings | Closed | |
| Sep 16, 2024 | Petition to open accelerated arrangement proceedings | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 19, 2019 | Merger registered | |
| Mar 17, 2015 | Commercial Companies Code notice |
Public aid
7 public aid cases recorded, with a total value of $19,325.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 25, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $206$206 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Nov 25, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $201$201 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Oct 10, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $206$206 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Trademarks
Adiuvo Investments holds 1 active trademark registered with the Polish Patent Office. 10 marks have expired or were not registered. The first mark was filed in 2015.
| Mark | Protected until | |
|---|---|---|
| Tribitor | Nov 4, 2026 | |
| ChylOmega(word) | – | |
| FITAMINS(word) | – | |
| TRInhibitor 3-PHASE CARBOHYDRATE BLOCKER | – | |
| TRINHIBITOR(word) | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will and sign on behalf of the company, whereas in the case of a multi-member management board, 2 members of the management board acting jointly or 1 member of the management board acting jointly with a commercial proxy are authorised to do so.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Adiuvo Investments.
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Adiuvo Managementsp. z o.o. | 27,012.43 USD | 100% | ||
Algaelabssp. z o.o. | 17,450.03 USD | 65.8512% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| AIP SeedS.A. | $4,424,276.84 | aipseed.com | ||
| Dom Inwestycyjny AniołówkaS.A. | $3,715,751.72 | aniolowkadominwestycyjny.eu | ||
| Invest Line ES.A. | $3,207,318.27 | ile.eu | ||
| Aper VenturesS.K.A. | $2,848,544.02 | aperventures.com | ||
| Blue Investments Asisp. z o.o. | $528,234.40 | blue-investments.pl | ||
| Aligo AlfaS.K.A. | $504,203.73 | aligo.vc | ||
| Szejk Capital AsiS.A. | $459,447.33 | szejkasi.pl | ||
| ABS InvestmentS.A. | $440,355.87 | absinvestment.pl | ||
| Innvesto Groupsp. z o.o. | $112,206.40 | innvesto.com | ||
| Assay Management AssayS.K.A. | $111,321.29 | assay.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-02-20 | Name change (Adiuvo Investments → Adiuvo Investments Spółka Akcyjna W Restrukturyzacji) | |
| 2024-03-26 | Address change (Ul. Gen. Józefa Zajączka 11/14, 01-510, Warszawa → Ul. Szara 10, 00-420, Warszawa) | |
| 2020-02-17 | Address change (Ul. Słomińskiego 15/509, 00-195, Warszawa → Ul. Gen. Józefa Zajączka 11/14, 01-510, Warszawa) | |
| 2019-05-10 | Share capital change (1,178,434.60 PLN → 1,317,434.60 PLN) | |
| 2018-11-08 | Share capital change (1,016,434.60 PLN → 1,178,434.60 PLN) |
FAQ
Last updated: 2026-03-24